- Home
- CFFI vs OBIO Comparison
CFFI vs OBIO Comparison
Compare CFFI & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFFI
- OBIO
- Stock Information
- Founded
- CFFI 1927
- OBIO 2017
- Country
- CFFI United States
- OBIO United States
- Employees
- CFFI N/A
- OBIO N/A
- Industry
- CFFI Major Banks
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- CFFI Finance
- OBIO Health Care
- Exchange
- CFFI Nasdaq
- OBIO Nasdaq
- Market Cap
- CFFI 248.5M
- OBIO 200.1M
- IPO Year
- CFFI 1998
- OBIO N/A
- Fundamental
- Price
- CFFI $72.50
- OBIO $4.79
- Analyst Decision
- CFFI
- OBIO Strong Buy
- Analyst Count
- CFFI 0
- OBIO 4
- Target Price
- CFFI N/A
- OBIO $15.75
- AVG Volume (30 Days)
- CFFI 12.4K
- OBIO 64.0K
- Earning Date
- CFFI 01-22-2025
- OBIO 11-12-2024
- Dividend Yield
- CFFI 2.41%
- OBIO N/A
- EPS Growth
- CFFI N/A
- OBIO N/A
- EPS
- CFFI 5.66
- OBIO N/A
- Revenue
- CFFI $114,783,000.00
- OBIO $2,647,000.00
- Revenue This Year
- CFFI N/A
- OBIO $12.39
- Revenue Next Year
- CFFI N/A
- OBIO $120.99
- P/E Ratio
- CFFI $12.89
- OBIO N/A
- Revenue Growth
- CFFI N/A
- OBIO N/A
- 52 Week Low
- CFFI $33.51
- OBIO $4.22
- 52 Week High
- CFFI $80.87
- OBIO $10.44
- Technical
- Relative Strength Index (RSI)
- CFFI 44.28
- OBIO 37.52
- Support Level
- CFFI $76.31
- OBIO $4.36
- Resistance Level
- CFFI $80.87
- OBIO $5.28
- Average True Range (ATR)
- CFFI 2.94
- OBIO 0.45
- MACD
- CFFI -1.07
- OBIO -0.07
- Stochastic Oscillator
- CFFI 14.95
- OBIO 23.65
About CFFI C&F Financial Corporation
C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum revenue from the Community Banking segment.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.